Venturini L - Search Results

1

In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells.

Calabresse C, Barbey S, Venturini L, Balitrand N, Degos L, Fenaux P, Chomienne C. Calabresse C, et al. Among authors: venturini l. Leukemia. 1995 Dec;9(12):2049-57. Leukemia. 1995. PMID: 8609716

2

Induction of the PML protein by interferons in normal and APL cells.

Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, Stadler M, Pavlovic J, Degos L, de Thé H. Chelbi-Alix MK, et al. Among authors: venturini l. Leukemia. 1995 Dec;9(12):2027-33. Leukemia. 1995. PMID: 8609713

3

Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate.

Calabresse C, Venturini L, Ronco G, Villa P, Degos L, Belpomme D, Chomienne C. Calabresse C, et al. Among authors: venturini l. Biochem Biophys Res Commun. 1994 May 30;201(1):266-83. doi: 10.1006/bbrc.1994.1698. Biochem Biophys Res Commun. 1994. PMID: 8198584

4

Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line.

Calabresse C, Venturini L, Ronco G, Villa P, Chomienne C, Belpomme D. Calabresse C, et al. Among authors: venturini l. Biochem Biophys Res Commun. 1993 Aug 31;195(1):31-8. doi: 10.1006/bbrc.1993.2005. Biochem Biophys Res Commun. 1993. PMID: 8363611

5

Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.

Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saïb A, Quignon F, Pelicano L, Guillemin MC, Schindler C, et al. Stadler M, et al. Among authors: venturini l. Oncogene. 1995 Dec 21;11(12):2565-73. Oncogene. 1995. PMID: 8545113

6

Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia.

Nagel S, Venturini L, Przybylski GK, Grabarczyk P, Schmidt CA, Meyer C, Drexler HG, Macleod RA, Scherr M. Nagel S, et al. Among authors: venturini l. Leuk Lymphoma. 2009 Jan;50(1):101-8. doi: 10.1080/10428190802626632. Leuk Lymphoma. 2009. PMID: 19148830

7

Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.

Nagel S, Venturini L, Meyer C, Kaufmann M, Scherr M, Drexler HG, Macleod RA. Nagel S, et al. Among authors: venturini l. Leuk Lymphoma. 2011 Feb;52(2):290-7. doi: 10.3109/10428194.2010.537003. Epub 2011 Jan 24. Leuk Lymphoma. 2011. PMID: 21261500

8

Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.

Scherr M, Elder A, Battmer K, Barzan D, Bomken S, Ricke-Hoch M, Schröder A, Venturini L, Blair HJ, Vormoor J, Ottmann O, Ganser A, Pich A, Hilfiker-Kleiner D, Heidenreich O, Eder M. Scherr M, et al. Among authors: venturini l. Leukemia. 2014 Mar;28(3):554-65. doi: 10.1038/leu.2013.361. Epub 2013 Nov 27. Leukemia. 2014. PMID: 24280866 Free PMC article.

9

Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.

Nagel S, Venturini L, Meyer C, Kaufmann M, Scherr M, Drexler HG, MacLeod RA. Nagel S, et al. Among authors: venturini l. Leuk Res. 2010 Apr;34(4):521-8. doi: 10.1016/j.leukres.2009.06.020. Epub 2009 Jul 15. Leuk Res. 2010. PMID: 19608273

10

TIF1gamma, a novel member of the transcriptional intermediary factor 1 family.

Venturini L, You J, Stadler M, Galien R, Lallemand V, Koken MH, Mattei MG, Ganser A, Chambon P, Losson R, de Thé H. Venturini L, et al. Oncogene. 1999 Feb 4;18(5):1209-17. doi: 10.1038/sj.onc.1202655. Oncogene. 1999. PMID: 10022127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters